You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-eIF4EBP1 antibody (ab2606)

CodeSizePriceAbpointsAvailability
    
Add to basket
 

  • -

  •   
  •   
  •   

  •  

  •  
  •  

  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab2606? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab2606 has been referenced in 5 publications.

  1. Jacobson BA et al. Activated 4E-BP1 represses tumourigenesis and IGF-I-mediated activation of the eIF4F complex in mesothelioma. Br J Cancer 101:424-31 (2009). WB; Human. PubMed: 19603014
  2. Zhang L et al. Individual overexpression of five subunits of human translation initiation factor eIF3 promotes malignant transformation of immortal fibroblast cells. J Biol Chem 282:5790-800 (2007). PubMed: 17170115
  3. Patel MR et al. Ras pathway activation in malignant mesothelioma. J Thorac Oncol 2:789-95 (2007). WB; Human. PubMed: 17805054
  4. Larsson O et al. Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. Cancer Res 67:6814-24 (2007). PubMed: 17638893
  5. Culjkovic B et al. eIF4E is a central node of an RNA regulon that governs cellular proliferation. J Cell Biol 175:415-26 (2006). PubMed: 17074885

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"